Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heike Bantel

Showing results (21-30 of 105) with videos related to

Pageof 11
Sort By:
Journal of Hepatology|March 26, 2013
The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off valuesRalf Lichtinghagen, Daniel Pietsch, Heike Bantel, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 14, 2025
Non-invasive Identification of Metabolic Dysfunction-associated Steatotic Liver Disease Patients Eligible for Resmetirom TreatmentKatharina John, Martin Franck, Andreas Geier, et al.
Cell Death & Disease|December 16, 2017
Increased apoptosis of regulatory T cells in patients with active autoimmune hepatitisKatharina John, Matthias Hardtke-Wolenski, Elmar Jaeckel, et al.
European Journal of Cancer (Oxford, England : 1990)|March 6, 2010
Serum biomarkers of cell death for monitoring therapy response of gastrointestinal carcinomasDoreen Brandt, Xandra Volkmann, Matthias Anstätt, et al.
European Journal of Gastroenterology & Hepatology|April 14, 2020
Liver stiffness across different chronic liver disease under therapy with statin in a real life cohortAntoaneta A Markova, Katja Deterding, Kerstin Port, et al.
Hepatology (Baltimore, Md.)|May 28, 2005
The extent of liver steatosis in chronic hepatitis C virus infection is mirrored by caspase activity in serumNicole Seidel, Xandra Volkmann, Florian Länger, et al.
Hepatology (Baltimore, Md.)|May 27, 2006
Caspase activation is required for antiviral treatment response in chronic hepatitis C virus infectionXandra Volkmann, Markus Cornberg, Heiner Wedemeyer, et al.
Plos One|November 14, 2015
Performance of Serum microRNAs -122, -192 and -21 as Biomarkers in Patients with Non-Alcoholic SteatohepatitisPhilip P Becker, Monika Rau, Johannes Schmitt, et al.
The Journal of Infectious Diseases|October 28, 2015
Interferon-Mediated Cytokine Induction Determines Sustained Virus Control in Chronic Hepatitis C Virus InfectionFranziska Wandrer, Christine S Falk, Katharina John, et al.
Plos One|January 4, 2013
Biopsy-controlled liver fibrosis staging using the enhanced liver fibrosis (ELF) score compared to transient elastographyKristin Wahl, William Rosenberg, Bernhard Vaske, et al.
Pageof 11

Showing results (21-30 of 105) with videos related to

Sort By:
Pageof 11
Journal of Hepatology|March 26, 2013
The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off valuesRalf Lichtinghagen, Daniel Pietsch, Heike Bantel, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 14, 2025
Non-invasive Identification of Metabolic Dysfunction-associated Steatotic Liver Disease Patients Eligible for Resmetirom TreatmentKatharina John, Martin Franck, Andreas Geier, et al.
Cell Death & Disease|December 16, 2017
Increased apoptosis of regulatory T cells in patients with active autoimmune hepatitisKatharina John, Matthias Hardtke-Wolenski, Elmar Jaeckel, et al.
European Journal of Cancer (Oxford, England : 1990)|March 6, 2010
Serum biomarkers of cell death for monitoring therapy response of gastrointestinal carcinomasDoreen Brandt, Xandra Volkmann, Matthias Anstätt, et al.
European Journal of Gastroenterology & Hepatology|April 14, 2020
Liver stiffness across different chronic liver disease under therapy with statin in a real life cohortAntoaneta A Markova, Katja Deterding, Kerstin Port, et al.
Hepatology (Baltimore, Md.)|May 28, 2005
The extent of liver steatosis in chronic hepatitis C virus infection is mirrored by caspase activity in serumNicole Seidel, Xandra Volkmann, Florian Länger, et al.
Hepatology (Baltimore, Md.)|May 27, 2006
Caspase activation is required for antiviral treatment response in chronic hepatitis C virus infectionXandra Volkmann, Markus Cornberg, Heiner Wedemeyer, et al.
Plos One|November 14, 2015
Performance of Serum microRNAs -122, -192 and -21 as Biomarkers in Patients with Non-Alcoholic SteatohepatitisPhilip P Becker, Monika Rau, Johannes Schmitt, et al.
The Journal of Infectious Diseases|October 28, 2015
Interferon-Mediated Cytokine Induction Determines Sustained Virus Control in Chronic Hepatitis C Virus InfectionFranziska Wandrer, Christine S Falk, Katharina John, et al.
Plos One|January 4, 2013
Biopsy-controlled liver fibrosis staging using the enhanced liver fibrosis (ELF) score compared to transient elastographyKristin Wahl, William Rosenberg, Bernhard Vaske, et al.
Pageof 11